📌 Key Takeaways
- A 2026 FIT study of 1,600+ consumers across 16 countries found only 5% trust influencers most—
while 75% cite dermatologists and physicians as their top source. - Scientific jargon (NAD+, exosomes, epigenetics) increases trust for only 14% of consumers—
while 56% want aging science explained in plain language. - 62% of GLP-1 users (Ozempic/Mounjaro) take the medication for appearance, not health—
driving a surge in body-contouring aesthetic demand. - 85% of consumers feel overwhelmed choosing beauty products,
reinforcing a shift back toward trusted human voices—especially physicians.
When you consider an aesthetic treatment, where do you turn first?
Social media, influencer posts, clinic ads, a friend’s recommendation, a doctor’s blog—
the sources are endless.
But which one do you actually trust?
In 2026, a graduate research team at the Fashion Institute of Technology (FIT) in New York
posed exactly that question to more than 1,600 people across 16 countries.
The answers challenge some of the beauty industry’s most deeply held assumptions.
16 Countries · 1,600+ Respondents · Mixed-Methods Survey
“most trusted” by just
5%
“But influencers drive sales—so they must be working,” you might think.
What this data reveals is that driving clicks and earning trust are two very different things.
This article unpacks the core findings of the FIT study
and draws out what they mean for the global aesthetic medicine landscape.
The most uncomfortable finding in the FIT report may be this one.
“Only 14% of consumers said terms like NAD+, exosomes,
or epigenetics make a brand feel more credible.
Meanwhile, 56% said they want aging science explained more clearly.”
→ Consumers want clarity—not credentials signaled through complexity.
The scientific vocabulary that brands deploy to project authority
may actually be eroding consumer confidence.
Jargon creates distance. Plain language builds trust.
Here is the complete data landscape from the FIT study.
Whether you are a consumer navigating aesthetic choices
or a practitioner building patient relationships,
these numbers matter.
The FIT study included a dedicated segment on GLP-1 users
(Ozempic, Mounjaro, Wegovy, and similar medications).
The findings contradict a common industry assumption.
of GLP-1 users take it primarily for appearance improvement
Only 29% cited health as their primary motivation.
This inverts the assumption that GLP-1 users are health-first consumers.
It also directly explains the surge in demand for skin-tightening
and body-contouring treatments following rapid weight loss.
of GLP-1 users purchased body care products
Demand for firming, skin elasticity, and muscle-support products
is expanding rapidly among this cohort.
Rapid weight loss from GLP-1 medications is creating
a new market segment for body-focused aesthetic medicine.
of GLP-1 users maintained beauty purchases under financial stress
(vs. 16% of non-users)
Even in economic downturns, GLP-1 users are significantly more likely
to sustain beauty spending.
They frame appearance investment as a form of ongoing self-investment—
not a discretionary luxury.
Let’s translate this data into practical implications
for aesthetic medicine providers globally.
“Physicians trusted by 75%, word-of-mouth at 45%, influencers at 5%”—
how much of this trust architecture is actually being leveraged
by clinics and practitioners today?
Question 1: Is your physician speaking in their own voice?
75% of consumers trust physicians above all others.
That means a single statement from a doctor
carries the trust equivalent of 15 influencer posts.
The question is whether clinics are putting that voice front and center—
or burying it behind brand messaging.
Question 2: Is plain-language communication your competitive edge?
Listing “NAD+” and “exosomes” impresses fewer than 1 in 7 consumers.
The clinic that can explain why a treatment works—
in clear, accessible language—
is the one that gets chosen.
Jargon works between specialists; for patients, it builds walls.
Question 3: Is the longevity + medicine intersection your strongest positioning?
58% of consumers believe longevity belongs to medicine, not beauty brands.
This is skepticism toward brands—but it is also an invitation to medical providers.
A physician-led approach integrating prevention, longevity, and aesthetics
is positioned to receive the highest level of consumer trust available.
📋 Four Macro Forces Behind This Consumer Shift (per FIT study)
Social uncertainty—Economic anxiety and inflation are intensifying demand for evidence-based guidance
Skepticism toward social mobility—A growing segment frames beauty as long-term self-investment, not external transformation
Cognitive fatigue—Information overload drives 85% to feel overwhelmed, pushing them back toward trusted human voices
Optimization mindset—Longevity, biometric data, and preventive medicine are increasingly entering the beauty conversation
Reading this study, my first reaction was recognition—not surprise.
“Physicians trusted 15× more than influencers.” “Jargon backfires.” “Word-of-mouth dominates.”
These findings align precisely with the editorial philosophy NERO has held since launch:
that aesthetic medicine should be chosen through understanding, not emotion.
At the same time, this data poses a direct challenge to the industry.
Physicians hold the most powerful trust asset in the entire beauty ecosystem—
yet too few clinics are deploying that asset through clear, direct communication.
In 2026, a single well-articulated sentence from a doctor
reaches patients more deeply than any influencer campaign.
Simply labeling a treatment “longevity” is no longer enough.
What the market demands now is a physician who can explain—
in plain language—why it works.
That clarity is the defining competitive advantage of 2026.
Summary
- The 2026 FIT study surveyed 1,600+ consumers across 16 countries.
Only 5% trust influencers most—while 75% trust physicians or dermatologists,
making doctors 15× more trusted than influencers. - Only 14% of consumers say scientific jargon (NAD+, exosomes, epigenetics)
increases brand credibility.
56% want aging science explained in plain language.
Overuse of technical terminology is counterproductive. - 62% of GLP-1 users (Ozempic/Mounjaro) use the medication for appearance—not health.
72% purchased body care products, signaling a major new demand segment
for body-focused aesthetic medicine. - The physician’s voice is the most valuable trust asset in aesthetic medicine.
Practitioners who communicate clearly and accessibly
hold the strongest competitive position going into 2026 and beyond.
Frequently Asked Questions
from correcting and reversing visible aging (anti-aging)
to preventing, maintaining, and optimizing skin health over time.
Core themes include sustained collagen production,
long-term skin barrier reinforcement,
and integration with lifestyle medicine.
The goal is not just “looking younger” but “skin that remains healthy long-term.”
Longevity-oriented treatments include biostimulators, PRF, and preventive skincare protocols.
Source: FIT CFMM Capstone 2026 “The Longevity of Beauty”; BeautyMatter, July 2, 2026
① Information published directly by dermatologists or physicians
(official media, physician blogs, academic presentations)
② Personal testimonials from friends or family who have undergone treatment
③ Media content with clearly identified physician oversight
Relying solely on influencer PR posts or clinic advertising carries significant risk.
The assumption that “more scientific terminology = more credible” is also misleading—
physicians who explain clearly in plain language tend to be more trustworthy.
Source: FIT CFMM Capstone 2026 “The Longevity of Beauty”; BeautyMatter, July 2, 2026
Among consumers aged 18–29, 72% prioritize resilience—
and 39% actively want more scientific explanation.
Among those aged 45–60, 57% are appearance-focused.
However, 47% of consumers over 60 view scientific claims as marketing,
and approach them with skepticism.
The implication: younger audiences respond to accessible science communication,
while older audiences are more persuaded by track record,
peer recommendations, and direct physician trust.
Source: FIT CFMM Capstone 2026 “The Longevity of Beauty”; BeautyMatter, July 2, 2026
Sources
1. FIT CFMM (Cosmetics and Fragrance Marketing and Management) Class of 2026. “The Longevity of Beauty.” Capstone Research. New York: Fashion Institute of Technology. 2026.
2. Condell O. “FIT Study Finds Longevity Is Reshaping Beauty Through Trust, Science, and Healthy Aging.” BeautyMatter. July 2, 2026.
3. BeautyMatter. “Longevity Is Reshaping Beauty as Consumers Demand Science, Personalization, and Proven Results.” June 28, 2026.
4. Technology.org. “Why Skin Longevity Is Becoming the Next Frontier of Cosmetic Science.” June 30, 2026.
This article is produced by the NERO DOCTOR/BEAUTY editorial team based on publicly available primary sources. It does not constitute endorsement of any specific brand or treatment.
